Paxil maker GlaxoSmithKline has agreed to pay several states $14 million to settle allegations that it blocked generic forms of Paxil, causing patients in those states to pay higher prices. GlaxoSmithKline was charged with filing frivolous patent-infringement lawsuits to allow it to extend Paxil's patent and thus keep generic versions of the drug off the market.
Read moreThis question has been on my mind lately after my son’s neurologist recommended a name-brand medication to treat his seizures instead of... Read more »
It's been seven weeks since I had my baby. The time is really flying by and soon my maternity leave will be over. I've been slowly... Read more »
Recently, a question was asked by one reader as to whether a generic form of an erectile dysfunction medication is different than the... Read more »
I have long been a supporter of generic medications. They are not only less expensive for me but they are less expensive for insurance... Read more »
I had always been told that the active ingredients in generic medications had to be exactly the same as their brand name counterparts; that... Read more »
The U.S. Supreme Court has upheld a lower court's ruling that Paxil does not deserve patent protection against generic formulas. GlaxoSmithKline... Read more »
Parents should be aware that generic versions of ADHD drugs are as safe and effective as name-brand meds, a new Consumer Reports Best Buy Drugs... Read more »
In an effort to compete with new generic formulas, Zocor maker Merck will continue to sell the brand-name form of the drug at a reduced price for the... Read more »
This is a study to determine if two medications, Paxil and Effexor, can help control depression in patients with Parkinson's disease. This national... Read more »
Some patients are finding that tapering off antidepressants like Paxil, Effexor, and Zoloft does not keep them from suffering difficult physical... Read more »